GT Solar Enters Contract to Supply Polysilicon Reactors and Converters

GT Solar Incorporated, a key global provider of a comprehensive range of equipment, services and technology solutions to the solar power industry, announced today that it has entered into a contract to supply Trina Solar (Lianyungang) Co., Ltd., a subsidiary of Trina Solar, Ltd. with polysilicon reactors and converters worth $49 MM. The equipment will be used by Trina Solar in conjunction with the company's announced plans to build and operate a multi-phased polysilicon production facility in Lianyungang, located in China's Jiangsu Province. The contract is subject to the approvals by the boards of both companies.

This $49 MM contract is for GT Solar's latest technology 48 rod chemical vapor deposition reactor and silicon tetrachloride (STC) hydrogenation conversion units, which convert STC to trichlrosilane (TCS).

GT Solar CEO, Thomas Zarrella, noted, "We are pleased to announce that this latest contract with Trina Solar reflects GT Solar's strategic role in meeting the global demand for polysilicon, which is a basic material for the manufacture of solar cells. Our technology and equipment continue to help the solar power industry meet the growth in product demand while helping the industry drive down the cost per kilowatt hour."

GT's VP for Polysilicon, David Keck, said: "Trina Solar is a recognized leader in manufacturing high quality monocrystalline and multicrystalline photovoltaic modules and is an important client to our team here at GT Solar. Trina Solar is focused on developing a strong brand in the marketplace, investing continuously in its technology platform and ensuring a low cost position, and we look forward to continuing to play a role in their success."

Jifan Gao, Chairman and CEO of Trina Solar, said: "As a customer of GT Solar, we have come to value GT's superior technology and equipment, and look forward to working together to continue to lower manufacturing costs as we increase our capacity and execute on our growth strategy."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.